Divalproex Sodium NDC 65862-959

Product information

Brand name (proprietary)

Divalproex Sodium

Generic name (nonproprietary)

divalproex sodium

Active ingredients

Divalproex sodium — 125 mg/1

Dosage form

Tablet, Delayed release

Route

Oral

Labeler

Aurobindo Pharma Limited

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 090554

Marketing start

Oct 24, 2014

Listing expires

Dec 31, 2027

Other FDA classes

Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)

Identifiers

Product ID 65862-959_3b5e2f9c-96b3-4b68-b0bb-91b0f4ef344bSPL ID 3b5e2f9c-96b3-4b68-b0bb-91b0f4ef344bSPL set ID dbd47222-14f1-4588-a009-9b81b55ca60dRxCUI 1099625, 1099678, 1099870UNII 644VL95AO6

Pharmacologic class

Anti-epileptic Agent; Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862095901 followed by a unit qualifier and the quantity Copy

Package 65862-0959-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 090554

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.